Investor List:

Top Therapeutics Pre-Seed Investors in Canada (7)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Therapeutics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of James C. Murray, Partner at ExSight Capital Management
James C. Murray
Sweet spot: $1M
Range: $200K - $4.0M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Pharmaceuticals (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Hardware (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Robotics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Hardware (Pre-seed), Investors in Robotics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Seed), Investors in Therapeutics (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Health & Hospital Services (Seed), Investors in Digital Health (Seed), Investors in Therapeutics (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Drug Delivery (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Medical Devices (Series A), Investors in Hardware (Series A), Investors in Diagnostics (Series A), Investors in Health & Hospital Services (Series A), Investors in Robotics (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Hardware (Series A), Investors in Robotics (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Therapeutics (Series B), Investors in Hardware (Series B), Investors in Pharmaceuticals (Series B), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Diagnostics (Series B), Investors in Robotics (Series B), Investors in Therapeutics (Series B), Investors in Drug Delivery (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Hardware (Series B), Investors in Robotics (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Canada (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists)
Photo of Sandra Pérez Baos, Analyst at 2048 Ventures
Sandra Pérez Baos
2048 Ventures·Analyst
Sweet spot: $1.3M
Range: $500 - $2.0M
Investors in Canada, Investors in United Kingdom, Investors in United States
Photo of William Szczepaniak, Managing Director at UCeed Funds
William Szczepaniak
UCeed Funds·Managing Director
Sweet spot: $150K
Range: $50K - $300K
Investors in United States, Investors in Canada, Investors in Calgary
Investors in Therapeutics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in Diagnostics (Seed), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Seed), Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Canada (Other Lists), Investors in Investors who were founders (Other Lists)
Photo of Samantha Tabone, Partner at Empath Ventures
Samantha Tabone
Sweet spot: $100K
Range: $50K - $250K
Investors in Canada, Investors in Australia, Investors in Europe, Investors in United Kingdom, Investors in United States
Photo of Thanasi Tsiodras, Angel at Genesis Ventures
Thanasi Tsiodras
Sweet spot: $25K
Range: $5K - $50K
Investors in Canada
Investors in Therapeutics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in E-commerce (Pre-seed), Investors in FinTech (Pre-seed), Investors in AI (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in E-commerce (Pre-seed), Investors in AI (Pre-seed), Investors in FinTech (Pre-seed), Investors in Therapeutics (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in E-commerce (Seed), Investors in AI (Seed), Investors in FinTech (Seed), Investors in Therapeutics (Seed), Investors in Medical Devices (Seed), Investors in E-commerce (Seed), Investors in AI (Seed), Investors in Health & Hospital Services (Seed), Investors in FinTech (Seed), Investors in Canada (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists)
Photo of Darryl Kirsh, Managing Partner
Darryl Kirsh
Managing Partner
Sweet spot: $500K
Range: $100K - $1M
Investors in Asia, Investors in Europe, Investors in Canada, Investors in United States
Investors in Pharmaceuticals (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Space (Pre-seed), Investors in AgTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Space (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in DeepTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Medical Devices (Seed), Investors in Space (Seed), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in DeepTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Drug Delivery (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Space (Seed), Investors in Medical Devices (Seed), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Seed), Investors in AgTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in British Columbia (Other Lists), Investors in Canada (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists)
Photo of Mack Luby, Associate at Mystic Ventures
Mack Luby
Mystic Ventures·Associate
Sweet spot: $250K
Range: $50K - $1M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Therapeutics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in AI (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in Therapeutics (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Drug Delivery (Seed), Investors in AI (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in AI (Seed), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Drug Delivery (Series A), Investors in AI (Series A), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Canada (Other Lists), Investors in Boston / New England (Other Lists), Investors in Investors who were founders (Other Lists)
Get new data & insights delivered to your inbox